Nuclear protein contents in peripheral blood mononuclear cells of trisomy 21 infants

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue 2, 2008, Pages 128-132

  Hamurcu, Zuhal ^a   Demirtas, Halil ^a   Patiroǧlu, Türkan ^a   Kumandas, Sefer ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Down's syndrome; Nuclear protein contents; PBMC; Trisomy 21

Indexed keywords

DNA; FLUORESCEIN ISOTHIOCYANATE; NUCLEAR PROTEIN; PROPIDIUM IODIDE;

ARTICLE; CELL ISOLATION; CELL NUCLEUS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFANT; LINEAR REGRESSION ANALYSIS; MALE; NEWBORN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; RANK SUM TEST; STATISTICAL ANALYSIS; TRISOMY 21;

AGE FACTORS; AGING; ANTIGENS, NUCLEAR; BIOLOGICAL MARKERS; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; MALE; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; UP-REGULATION;

EID: 42549134852     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20387     Document Type: Article

References (41)

1. Amano K, Sago H, Uchikawa C, Suzuki T, Kotliarova SE, Nukina N, Epstein CJ, Yamakawa K. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Hum Mol Genet 2004;13:1333-1340.
2. Mao R, Wang X, Spitznagel EL Jr, Frelin LP, Ting JC, Ding H, Kim JW, Ruczinski I, Downey TJ, Pevsner J. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol 2005;6:R107.
3. Kahlem P. Gene-dosage effect on chromosome 21 transcription in trisomy 21: Implication in Down syndrome cognitive disorders. Behav Genet 2006;36:416-428.
4. Roper RJ, Reeves RH. Understanding the basis for Down syndrome phenotypes. PLoS Genet 2006;2:231-236.
5. Roubertoux PL, Kerdelhué B. Trisomy 21: From chromosomes to mental retardation. Behav Genet 2006;36:346-354.
6. Gardiner K. Transcriptional dysregulation in Down syndrome: Predictions for altered protein complex stoichiometries and post-translational modifications, and consequences for learning/behavior genes ELK, CREB, and the estrogen and glucocorticoid receptors. Behav Genet 2006;36:439-453.
7. Li CM, Guo M, Salas M, Schupf N, Silverman W, Zigman WB, Husain S, Warburton D, Thaker H, Tycko B. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet 2006;7:24.
8. Antonarakis SE, Epstein CJ. The challenge of Down syndrome. Trends Mol Med 2006;12:473-479.
9. Ronan A, Fagan K, Christie L, Conroy J, Nowak N, Turner G. Familial 4.3Mb duplication of 21q22 sheds new light on the Down Syndrome critical region. J Med Genet 2007;44:448-451.
10. Arron JR, Winslow MM, Polleri A, Chang C-P, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 2006;441:595-600.
11. Delabar J, Theophile D, Rahmani Z, Blouin J, Prieur M, Noel B, Sinet P. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet 1993;1:114-124.
12. Ma H, Xiong H, Liu T, Zhang L, Godzik A, Zhang Z. Aggregate formation and synaptic abnormality induced by DSCR1. J Neurochem 2004;88:1485-1496.
13. Vesa J, Brown Y, Greenfield D, Korenberg JR. Molecular and cellular characterization of the Down syndrome critical region protein 2. Biochem Biophys Res Commun 2005;328:235-242.
14. Olson LE, Roper RJ, Sengstaken CL, Peterson EA, Aquino V, Galdzicki Z, Siarey R, Pletnikov M, Moran TH, Reeves RH. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Hum Mol Genet 2007;16:774-782.
15. Nikolaienko O, Nguyen C, Crinc LS, Cios KJ, Gardiner K. Human chromosome 21/Down syndrome gene function and pathway database. Gene 2005;364:90-98.
16. Korenberg J. Down syndrome phenotype mapping. In: Epstein C, editor. Progress in Clinical and Biological Research, Vol. 373. New York: Wiley-Liss; 1991. pp 43-52.
17. Minami T, Miura M, Aird WC, Kodama T. Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. J Biol Chem 2006;281:20503-20520.
18. Pfister SC, Machado-Santelli GM, Han SW, Henrique-Silva F. Mutational analyses of the signals involved in the subcellular location of DSCR1. BMC Cell Biol 2002;3:24.
19. Qin L, Zhao D, Liu X, Nagy JA, Hoang MV, Brown LF, Dvorak HF, Zeng H. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway. Mol Cancer Res 2006;4:811-820.
20. Ferrando-Miguel R, Cheon MS, Lubec G. Protein levels of genes encoded on chromosome 21 in fetal Down Syndrome brain (Part V): Overexpression of phosphatidyl-inositol-glycan class P protein (DSCR5). Amino Acids 2004;26:255-261.
21. Shibuya K, Kudoh J, Minoshima S, Kawasaki K, Asakawa S, Shimizu N. Isolation of two novel genes, DSCR5 and DSCR6, from Down syndrome critical region on human chromosome 21q22.2. Biochem Biophys Res Commun 2000;271:693-698.
22. Risinger JI, Chandramouli GV, Maxwell GL, Custer M, Pack S, Loukinov D, Aprelikova O, Litzi T, Schrump DS, Murphy SK, Berchuck A, Lobanenkov V, Barrett JC. Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression. Clin Cancer Res 2007;13:1713-1719.
23. Takamatsu K, Maekawa K, Togashi T, Choi DK, Suzuki Y, Taylor TD, Toyoda A, Sugano S, Fujiyama A, Hattori M, Sakaki Y, Takeda T. Identification of two novel primate-specific genes in DSCR. DNA Res 2002;9:89-97.
24. Hamurcu Z, Demirtas H, Kumandas S. Flow cytometric comparison of RNA content in peripheral blood mononuclear cells of Down syndrome patients and control individuals. Cytometry B Clin Cytom 2006;70:24-28.
25. Hamurcu Z, Demirtas H, Patiroglu T, Kumandas S, Imamoglu N, Ozkul Y, Donmez-Altuntas H. Age-dependent decreases in mitogen-stimulation level and RNA content in peripheral blood mononuclear cells of Down syndrome patients. Cytometry B Clin Cytom 2007;72: 43-48.
26. Imamoglu N, Demirtas H, Donmez-Altuntas H, Ilten A. Higher NORs expression in lymphocyte of trisomy 21 babies/children: In vivo evaluation. Micron 2005;36:503-507.
27. Imamoglu N, Demirtas H, Ilten A. NOR expression increases in interphase lymphocytes of Down syndrome babies/children as AgNOR surface, according to the mitogen concentration in the culture medium. Micron 2006;37:129-133.
28. Imamoglu N, Demirtas H, Donmez-Altuntas H, Hamurcu Z, Ilten A. NOR expression increase on metaphase chromosomes of Down syndrome lymphocytes in concordance with mitogen concentration in culture medium. Cytometry B Clin Cytom 2005;66:36-39.
29. Demirtas H, Imamoglu N, Donmez H, Cucer N, Yilmaz A, Candemir Z. Condensed chromatin surface and NORs surface enhancement in mitogen-stimulated lymphocytes of Down syndrome patients. Ann Genet Paris 2001;44:77-82.
30. Demirtas H, Imamoglu N, Cucer N, Donmez H, Yilmaz A, Candemir Z, Bokesoy I. NORs (rDNA) expression enhancement in phytohemagglutinin-stimulated lymphocytes of Down syndrome patients. Erciyes Univ J Health Sci 1999;8:24-27.
31. Robinson JP, editor. Handbook of Flow Cytometry Methods. New York: Wiley-Liss; 1993. p 109.
32. Petit JM, Denis-Gay M, Ratinaud MH. Assessment of fluorochromes for cellular structure and function studies by flow cytometry. Biol Cell 1993;78:1-13.
33. Pollack A, Moulis H, Block NL, Irvin GL III. Quantitation of cell kinetic responses using simultaneous flow cytometric measurements of DNA and nuclear protein. Cytometry 1984;5:473-481.
34. Roti Roti JL, Higashikubo R, Blair OC, Uygur N. Cell-cycle position and nuclear protein content. Cytometry 1982;3:91-96.
35. Dawson-Sonders B, Trapp RG. Basic and Clinical Statistics. London: Prentice-Hall; 1990. p 56.
36. Roussel P, Hernandez-Verdun D. Identification of Ag-NOR proteins, markers of proliferation related to ribosomal genes activity. Exp Cell Res 1994;214:465-472.
37. Derenzini M, Sirri V, Trere D, Ochs RI. The quantity of nucleolar proteins nucleolin and B23 is related to cell doubling time in human cancer cells. Lab Invest 1995;73:1-6.
38. Sirri V, Roussel P, Gendron MC, Hernandez-Verdun D. Amount of the two major Ag-NOR proteins, nucleolin and protein B23 is cell-cycle dependent. Cytometry 1997;28:147-156.
39. Yu Y, Maggi LB, Brady SN, Apicelli AJ, Dai MS, Lu H, Weber JD. Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol Cell Biol 2006;26:3798-3809.
40. Nissan TA, Bassler J, Petfalski E, Tollervey D, Hurt E. 60S pre-ribosome formation viewed from assembly in the nucleolus until export to the cytoplasm. EMBO J 2002;21:5539-5547.
41. Johnson AW, Lund E, Dahlberg J. Nuclear export of ribosomal subunits. Trends Biochem Sci 2002;27:580-585.